Expert CRO, specialized in the Central Europe, Eastern Balkans and Türkiye , with
Our services are flexible thanks to our Functional Service Provider (FSP Model) which works well for small and mid-sized Biotech with PIPELINE in development and CROs that need coverage in our region, that mainly have their own capabilities. We provide tailor made solution for:
Our Exprience is defined by more than two dozens Clinical Trials completed in the past 6 years.
See trials
Founded in 2019, Rosenbaum Group has grown from an entrepreneurial vision into an operational team of over 20 professionals with experience across leading international CROs. We specialize in navigating complex European regions, where operational expertise, local insight, and execution excellence make the difference between delay and delivery. Our focus is clear: reliable outcomes, efficient patient recruitment, operational excellence, and a sustainable return on investment.
We know how important is to know Sites & Investigators when it comes to recruitment, quality and delivery.
Through long‑standing professional relationships, we collaborate with a carefully selected group of investigators and site teams who share our commitment to quality and performance. This close cooperation enables strong patient recruitment results, with enrollment goals often achieved on time.
Inflammatory bowel disease (IBD): Ulcerative colitis (UC), Crohn’s disease (CD), fibrostenosing Crohn’s disease, pouchitis Eosinophilic gastrointestinal diseases (EGIDs): Eosinophilic esophagitis (EoE) Microscopic colitis Celiac disease (CeD) Functional and motility disorders of the gastrointestinal tract: Gastroparesis Familial adenomatous polyposis (FAP) Inflammatory liver conditions: Primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC)
NSCLC, Breast Cancer, Prostate Cancer, Ovarian Cancer, Pancreatic Cancer, Colorectal Cancer, Advanced Melanoma
Multiple Sclerosis, Spasticity, neuropathic pain and other neurological indications
Antimicrobial and Antifungal infections and other ID.
Heart Failure Valvular heart disease Dilative and Hypertrophic Cardiomyopathy Chronic Myocarditis Coronary Artery Disease & Atherosclerosis Cardiac Arrhythmia Pulmonary Arterial Hypertension Acute Ischemic Stroke
Major Depressive Disorders, Schizophrenia & Schizoaffective, Agitation – Schizophrenia & Bipolar Disorders, Treatment-Resistant Depression
Rheumatoid Arthritis, Psoriatic Arthritis, lupus erythematosus, Psoriasis
Albania
Austria
Bulgaria
Czech Republic
Denmark
Germany
Greece
Italy
Kosovo
Montenegro
Poland
Serbia
Slovakia
Türkiye
Rosenbaum Research Offices
Rosenbaum Research Operational presence
Our CRO Model is approved by Reuters Pharma Awards and BIOTECH Industry